Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Top 2 Risk Off Stocks You May Want To Dump In Q2

Published 23/04/2024, 12:49
© Reuters.  Top 2 Risk Off Stocks You May Want To Dump In Q2

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

As of April 23, 2024, two stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.

Here's the latest list of major overbought players in this sector.

Moolec Science SA (NASDAQ:MLEC)

  • On April 22, Moolec Science said it received approval for its plant-grown animal proteins. The Animal and Plant Health Inspection Service (APHIS) of the U.S. Department of Agriculture (USDA) has concluded its Regulatory Status Review (RSR) for Moolec's genetically engineered (GE) soybean Piggy Sooy. "We achieved an unprecedented milestone in biotechnology with the first-ever USDA-APHIS approval of this kind," stated CEO and Co-Founder Gastón Paladini. The company's stock gained around 106% over the past five days and has a 52-week high of $4.40.
  • RSI Value: 71.26
  • MLEC Price Action: Shares of Moolec Science jumped 79% to close at $2.47 on Monday.
Yatsen Holding Limited (NYSE:YSG)
  • On April 11, Yatsen regained compliance with NYSE minimum price continued listing criterion. The company's stock gained around 83% over the past month and has a 52-week high of $6.65.
  • RSI Value: 79.76
  • YSG Price Action: Shares of Yatsen Holding gained 1.3% to close at $3.80 on Monday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Also Read This:

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.